{
  "id": "domain-3-ch12-sleep-wake",
  "name": "Ch 12: Sleep-Wake Disorders",
  "domain": "Domain 3: Clinical Psychopathology",
  "questions": [
    {
      "type": "single-choice",
      "id": "d3-fes-004",
      "stem": "A patient reports falling asleep within 3 minutes of lying down, experiencing vivid dreams during brief naps, and 'losing muscle control' when laughing. Polysomnography shows sleep-onset REM periods. Which neurotransmitter system abnormality is most implicated in this condition?",
      "options": [
        "Excessive GABAergic activity in the reticular formation",
        "Deficiency of orexin/hypocretin in the lateral hypothalamus",
        "Dopamine dysregulation in the substantia nigra",
        "Serotonin depletion in the raphe nuclei"
      ],
      "correctAnswer": 1,
      "explanation": "This presentation is classic narcolepsy Type 1 with cataplexy (muscle weakness with emotion) and sleep-onset REM periods. Research has established that narcolepsy Type 1 results from loss of orexin (hypocretin)-producing neurons in the lateral hypothalamus, likely due to autoimmune destruction. CSF orexin levels are typically very low or undetectable in these patients.",
      "difficulty": "hard",
      "tags": [
        "narcolepsy",
        "orexin",
        "sleep-wake neuroscience"
      ]
    },
    {
      "type": "multiple-choice",
      "id": "d3-fes-008",
      "stem": "A sleep study for a patient with excessive daytime sleepiness shows an apnea-hypopnea index (AHI) of 22 events/hour. Which findings would indicate obstructive rather than central sleep apnea? (Select all that apply)",
      "options": [
        "Continued respiratory effort during apneic events",
        "Oxygen desaturation following events",
        "Absence of airflow with absent respiratory effort",
        "Loud snoring and gasping arousals",
        "Upper airway collapse visualized on endoscopy"
      ],
      "correctAnswers": [
        0,
        3,
        4
      ],
      "explanation": "Obstructive sleep apnea is characterized by continued respiratory effort against a collapsed airway (distinguishing it from central apnea where effort is absent), loud snoring from partial obstruction, and demonstrable upper airway collapse. Oxygen desaturation occurs in both types. Central sleep apnea shows absence of both airflow AND respiratory effort.",
      "difficulty": "hard",
      "tags": [
        "sleep apnea",
        "obstructive vs central",
        "polysomnography"
      ]
    },
    {
      "type": "matrix-single",
      "id": "d3-fes-011",
      "stem": "Match each sleep disorder with its most characteristic polysomnographic finding.",
      "rows": [
        "Narcolepsy Type 1",
        "REM sleep behavior disorder",
        "Periodic limb movement disorder",
        "Central sleep apnea"
      ],
      "columns": [
        "Sleep-onset REM periods",
        "Loss of REM atonia",
        "Repetitive leg EMG activity",
        "Absent respiratory effort with apnea"
      ],
      "correctAnswers": {
        "Narcolepsy Type 1": "Sleep-onset REM periods",
        "REM sleep behavior disorder": "Loss of REM atonia",
        "Periodic limb movement disorder": "Repetitive leg EMG activity",
        "Central sleep apnea": "Absent respiratory effort with apnea"
      },
      "explanation": "Narcolepsy Type 1 shows sleep-onset REM periods (SOREMPs) on MSLT. REM sleep behavior disorder shows REM without atonia, allowing dream enactment. PLMD shows periodic limb movements during sleep on leg EMG. Central sleep apnea shows apneic events without respiratory effort (versus obstructive where effort continues).",
      "difficulty": "hard",
      "tags": [
        "sleep disorders",
        "polysomnography",
        "differential diagnosis"
      ]
    },
    {
      "type": "matrix-multiple",
      "id": "d3-fes-014",
      "stem": "For each sleep disorder, select ALL appropriate first-line treatments.",
      "rows": [
        "Chronic insomnia disorder",
        "Narcolepsy with cataplexy",
        "Obstructive sleep apnea (moderate)"
      ],
      "columns": [
        "CBT-I",
        "Modafinil",
        "CPAP therapy",
        "Sodium oxybate",
        "Benzodiazepine receptor agonists"
      ],
      "correctAnswers": {
        "Chronic insomnia disorder": [
          "CBT-I"
        ],
        "Narcolepsy with cataplexy": [
          "Modafinil",
          "Sodium oxybate"
        ],
        "Obstructive sleep apnea (moderate)": [
          "CPAP therapy"
        ]
      },
      "explanation": "CBT-I is first-line for chronic insomnia (superior long-term outcomes to medications). For narcolepsy with cataplexy, modafinil treats sleepiness and sodium oxybate (Xyrem) uniquely treats both sleepiness and cataplexy. CPAP is first-line for moderate-severe OSA. BzRA agonists are second-line for insomnia due to dependency risks.",
      "difficulty": "hard",
      "tags": [
        "sleep disorders",
        "treatment guidelines",
        "first-line therapy"
      ]
    },
    {
      "type": "cloze-dropdown",
      "id": "d3-fes-016",
      "stem": "A patient reports difficulty initiating sleep, taking 90 minutes to fall asleep most nights for the past 4 months. They have developed anxiety about bedtime and spend extended time in bed trying to sleep. Sleep diary shows sleep efficiency of 62%. According to CBT-I protocols, the intervention targeting their extended time in bed is [[1]], while the intervention for their anxiety about sleep is [[2]]. The recommended sleep efficiency threshold before extending time in bed is [[3]].",
      "options": {
        "1": [
          "Sleep restriction therapy",
          "Stimulus control",
          "Relaxation training",
          "Paradoxical intention"
        ],
        "2": [
          "Cognitive restructuring",
          "Sleep restriction therapy",
          "Sleep hygiene education",
          "Stimulus control"
        ],
        "3": [
          "75%",
          "80%",
          "85%",
          "90%"
        ]
      },
      "correctAnswers": {
        "1": "Sleep restriction therapy",
        "2": "Cognitive restructuring",
        "3": "85%"
      },
      "explanation": "Sleep restriction limits time in bed to match actual sleep time, increasing sleep pressure and efficiency. Cognitive restructuring addresses dysfunctional beliefs and anxiety about sleep. In CBT-I protocols, time in bed is increased by 15-minute increments when sleep efficiency reaches 85% or higher.",
      "difficulty": "hard",
      "tags": [
        "insomnia",
        "CBT-I",
        "behavioral sleep medicine"
      ]
    },
    {
      "type": "bowtie",
      "id": "d3-fes-018",
      "stem": "A 45-year-old man presents with excessive daytime sleepiness, loud snoring, witnessed apneic episodes, and morning headaches. His BMI is 34 and neck circumference is 18 inches. Epworth Sleepiness Scale score is 16.",
      "centerStatement": "Most likely diagnosis",
      "leftColumn": {
        "header": "Risk Factors Present",
        "options": [
          "Obesity (BMI >30)",
          "Male gender",
          "Large neck circumference (>17 inches)",
          "Witnessed apneas by bed partner"
        ]
      },
      "rightColumn": {
        "header": "Indicated Interventions",
        "options": [
          "Diagnostic polysomnography",
          "Continuous positive airway pressure (CPAP)",
          "Weight loss counseling",
          "Immediate prescription of modafinil"
        ]
      },
      "correctAnswers": {
        "center": "Obstructive sleep apnea",
        "left": [
          "Obesity (BMI >30)",
          "Male gender",
          "Large neck circumference (>17 inches)",
          "Witnessed apneas by bed partner"
        ],
        "right": [
          "Diagnostic polysomnography",
          "Continuous positive airway pressure (CPAP)",
          "Weight loss counseling"
        ]
      },
      "explanation": "This presentation strongly suggests obstructive sleep apnea. All listed factors are established risk factors for OSA. Polysomnography is needed for diagnosis and severity assessment. CPAP is first-line treatment for moderate-severe OSA, and weight loss is an important adjunct. Modafinil would be premature before PSG confirmation and CPAP trial.",
      "difficulty": "hard",
      "tags": [
        "obstructive sleep apnea",
        "diagnosis",
        "treatment"
      ]
    },
    {
      "type": "drag-drop-ordered",
      "id": "d3-fes-022",
      "stem": "A patient has chronic insomnia and is starting CBT-I. Arrange these sleep restriction therapy steps in the correct order.",
      "options": [
        "Calculate average total sleep time from 2-week sleep diary",
        "Set initial prescribed time in bed equal to average sleep time (minimum 5 hours)",
        "Maintain consistent wake time regardless of sleep quality",
        "When sleep efficiency reaches 85%, increase time in bed by 15 minutes",
        "Continue adjustments until optimal sleep duration achieved"
      ],
      "correctOrder": [
        0,
        1,
        2,
        3,
        4
      ],
      "explanation": "Sleep restriction begins with calculating baseline sleep from diary data, then prescribing time in bed matching actual sleep (â‰¥5 hours minimum for safety). Consistent wake time is maintained to consolidate sleep. Time in bed increases only when efficiency reaches 85%, continuing until optimal personal sleep need is established.",
      "difficulty": "hard",
      "tags": [
        "sleep restriction",
        "CBT-I",
        "insomnia treatment"
      ]
    },
    {
      "type": "drag-drop-categorize",
      "id": "d3-fes-025",
      "stem": "Categorize each sleep phenomenon according to whether it is a normal sleep finding or a pathological finding requiring clinical attention.",
      "categories": [
        "Normal Sleep Finding",
        "Pathological Finding"
      ],
      "items": [
        "Sleep latency of 15-20 minutes",
        "Sleep onset REM period on MSLT",
        "Periodic limb movements <5/hour",
        "REM sleep without atonia on PSG",
        "Sleep efficiency of 88%",
        "Apnea-hypopnea index of 18/hour"
      ],
      "correctCategorization": {
        "Normal Sleep Finding": [
          "Sleep latency of 15-20 minutes",
          "Periodic limb movements <5/hour",
          "Sleep efficiency of 88%"
        ],
        "Pathological Finding": [
          "Sleep onset REM period on MSLT",
          "REM sleep without atonia on PSG",
          "Apnea-hypopnea index of 18/hour"
        ]
      },
      "explanation": "Normal: sleep latency 15-20 minutes, PLMI <5/hour is normal, sleep efficiency >85% is healthy. Pathological: SOREMPs suggest narcolepsy, REM without atonia indicates REM sleep behavior disorder risk, AHI 15-30 indicates moderate sleep apnea requiring treatment.",
      "difficulty": "hard",
      "tags": [
        "polysomnography",
        "sleep disorders",
        "normal vs pathological"
      ]
    }
  ]
}
